MedPath
FDA Approval

Ondansetron Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
DOH CENTRAL PHARMACY
DUNS: 829348114
Effective Date
January 22, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ondansetron(4 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

DOH CENTRAL PHARMACY

DOH CENTRAL PHARMACY

829348114

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ondansetron Hydrochloride

Product Details

NDC Product Code
53808-1121
Application Number
ANDA078539
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 22, 2019
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6Class: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
Code: NMH84OZK2BClass: ACTIMQuantity: 4 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath